MedTrace Logo

Impact of Smoking and Its Cessation on Systemic and Airway Immune Activation

NCT02836067 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 53

Last updated 2024-01-05

No results posted yet for this study

Summary

The purpose of this study is to learn how smoking affects the immune systems in people with HIV infection. The investigators would like to know if HIV infected smokers who quit smoking have different responses in their tissues from people who keep smoking.

Conditions

Interventions

BEHAVIORAL

Counseling

Smoking cessation counseling

OTHER

Smoking Cessation drugs

Medication to aid smoking cessation

PROCEDURE

Bronchoscopy

Bronchoscopy

PROCEDURE

Blood Draw

Screening and research blood draws

BEHAVIORAL

Questionnaires

Behavioral questionnaires

Sponsors & Collaborators

  • National Institute on Drug Abuse (NIDA)

    collaborator NIH

  • Boston Medical Center

    lead OTHER

Principal Investigators

  • Archana Asundi, M.D. · Boston Medical Center

Study Design

Allocation
NON_RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-06-15
Primary Completion
2023-12-31
Completion
2023-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02836067 on ClinicalTrials.gov